3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
9
Lymphoma, Non-Hodgkin
7
Recurrence
2
Lymphoma
2
Cytokine Release Syndrome
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Craniopharyngioma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Burkitt Lymphoma
1
Astrocytoma
1
Advanced Liver Cancers
1
Interventions
pembrolizumab
6
avelumab
6
Nivolumab
5
Specimen Handling
4
Magnetic Resonance Spectroscopy
3
Biopsy
3
prednylidene
2
lutetium Lu 177 dotatate
2
deltacortene
2
Prednisone
2
Ipilimumab
2
CTLA-4 Antigen
2
talimogene laherparepvec
1
lenvatinib
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
aldesleukin
1
Tacrolimus
1
Sirolimus
1
Saline Solution
1
Radiotherapy
1
Radiosurgery
1
MAPRE1 protein, human
1
Lutetium-177
1
Laparoscopy
1
Exercise Test
1
Cyclophosphamide
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Merkel Cell
×
tocilizumab
×
90 days
×
Clear all
No trials found.